Bioinspired thiazolo-[2,3-b] quinazolin-6-one derivatives as potent anti-cancer agents targeting EGFR: their biological evaluations and in silico assessment

SA Mir, PP Mohanta, RK Meher, I Baitharu… - Molecular Diversity, 2023 - Springer
Cancer is a challenging and second most deadly disease. The epidermal growth factor
receptors (EGFRs) dimerize upon ligand bindings to the extracellular domain that intiates …

In silico and in vitro evaluations of fluorophoric thiazolo-[2, 3-b] quinazolinones as anti-cancer agents targeting EGFR-TKD

SA Mir, GC Dash, RK Meher, PP Mohanta… - Applied Biochemistry …, 2022 - Springer
Epidermal growth factor receptor tyrosine kinase domain (EGFR-TKD) plays a pivotal role in
cellular signaling, growth, and metabolism. The EGFR-TKD is highly expressed in cancer …

Quinoline‐based thiazolidinone derivatives as potent cytotoxic and apoptosis‐inducing agents through EGFR inhibition

MS Nafie, SM Kishk, S Mahgoub… - Chemical Biology & …, 2022 - Wiley Online Library
Quinoline‐based thiazolidinone heterocycles exhibited potent activity in the field of cancer
therapy. Hence, ten quinoline‐based thiazolidinone derivatives were evaluated for their …

Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with …

WM Eldehna, MA El Hassab, ZM Elsayed, T Al-Warhi… - Scientific reports, 2022 - nature.com
Currently, the humanity is in a fierce battle against various health-related challenges
especially those associated with human malignancies. This created the urge to develop …

Novel 2-(5-Aryl-4, 5-dihydropyrazol-1-yl) thiazol-4-one as EGFR inhibitors: synthesis, biological assessment and molecular docking insights

T Al-Warhi, AM El Kerdawy, MA Said… - Drug Design …, 2023 - Taylor & Francis
Introduction Epidermal growth factor receptor (EGFR) regulates several cell functions which
include cell growth, survival, multiplication, differentiation, and apoptosis. Currently, EGFR …

[HTML][HTML] Structural insights into conformational stability and binding of thiazolo-[2, 3-b] quinazolinone derivatives with EGFR-TKD and in-vitro study

SA Mir, PP Mohanta, RK Meher, MK Raval… - Saudi Journal of …, 2022 - Elsevier
Heterocyclic molecules are well-known drugs against various diseases including cancer.
Many tyrosine kinase inhibitors including erlotinib, osimertinib, and sunitinib were …

Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and …

S Magdy Eldaly, D Salama Zakaria… - Chemistry & …, 2023 - Wiley Online Library
Synthesis of new anticancer candidates with protein kinases inhibitory potency is a major
goal of pharmaceutical science and synthetic research. This current work represents the …

Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological …

SM Al-Muntaser, AA Al-Karmalawy, AM El-Naggar… - RSC …, 2023 - pubs.rsc.org
In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …

Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo [3, 4-d] Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell …

FF Sherbiny, AH Bayoumi, AM El-Morsy, M Sobhy… - Bioorganic …, 2021 - Elsevier
A series of novel hybrid pyrazolo [3, 4-d] pyramidine derivatives was designed and
chemically synthesized in useful yields. The synthesized compounds were structurally …

Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido [2, 3-d] pyrimidine derivatives targeting epidermal growth factor receptor

J Hou, S Wan, G Wang, T Zhang, Z Li, Y Tian… - European Journal of …, 2016 - Elsevier
Three series of novel quinazoline and pyrido [2, 3-d] pyrimidine derivatives were designed,
synthesized and evaluated for their ability to inhibit EGFR tyrosine kinase and a panel of five …